NSCLC - Non Small Cell Lung Cancer Now Closed
CCTG BR.31 - Hosted By elie
Save
Bookmark
Print
| Sponsor Name | |
| Tumor Site | NSCLC - Non Small Cell Lung Cancer |
| Disease Stage | Stage I, Stage II, Stage III |
| Clinical Status | Adjuvant, Operable |
| Phase | Phase III |
| Intervention / Treatment | Durvalumab versus Placebo |
| Research Site | Quebec, Quebec Heart and Lung Institute |
| Investigator | Dre Lise Tremblay |
| Telephone Number | +1 418 656-8711 |
| Study Start Date | October 9, 2014 |
| Study End Date | January 1, 2023 |
| Trial Status | Recruitment |
